---
title: "12 Health Care Stocks Moving In Thursday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281559112.md"
description: "In Thursday's intraday session, several health care stocks experienced significant movements. Profusa (NASDAQ:PFSA) surged 48.6% to $0.86, while Cocrystal Pharma (NASDAQ:COCP) rose 45.1% to $1.48. Bristol-Myers Squibb's Celgene Contingent Value Rights (NYSE:CELGR) increased by 35.32% to $0.12. Conversely, Lipocine (NASDAQ:LPCN) plummeted 78.4% to $2.0, and Inovio Pharmaceuticals (NASDAQ:INO) fell 36.9% to $1.1. Overall, the session saw notable gains and losses among various health care stocks."
datetime: "2026-04-02T17:05:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281559112.md)
  - [en](https://longbridge.com/en/news/281559112.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281559112.md)
---

# 12 Health Care Stocks Moving In Thursday's Intraday Session

### Gainers

-   **Profusa** (NASDAQ:PFSA) stock rose 48.6% to $0.86 during Thursday's regular session.
-   **Cocrystal Pharma** (NASDAQ:COCP) shares rose 45.1% to $1.48. The market value of their outstanding shares is at $14.0 million. As per the news, the Q4 earnings report came out 2 days ago.
-   **Bristol-Myers Squibb Company Celegne Contingent Value Rights** (NYSE:CELGR) stock increased by 35.32% to $0.12.
-   **Axe Compute** (NASDAQ:AGPU) shares rose 20.78% to $4.3. The market value of their outstanding shares is at $12.0 million. As per the press release, Q4 earnings came out 2 days ago.
-   **Relay Therapeutics** (NASDAQ:RLAY) shares rose 19.68% to $12.89. The market value of their outstanding shares is at $1.8 billion.
-   **Lexaria Bioscience** (NASDAQ:LEXX) stock rose 18.92% to $1.03. The company's market cap stands at $21.5 million.

### Losers

-   **Lipocine** (NASDAQ:LPCN) shares decreased by 78.4% to $2.0 during Thursday's regular session. The market value of their outstanding shares is at $67.5 million.
-   **Inovio Pharmaceuticals** (NASDAQ:INO) stock fell 36.9% to $1.1. The market value of their outstanding shares is at $120.2 million.
-   **IO Biotech** (NASDAQ:IOBT) shares declined by 26.09% to $0.03. The company's market cap stands at $3.1 million.
-   **Bullfrog AI Hldgs** (NASDAQ:BFRG) stock declined by 24.08% to $1.23. The company's market cap stands at $20.5 million.
-   **Onconetix** (NASDAQ:ONCO) stock decreased by 21.08% to $1.48. The market value of their outstanding shares is at $1.2 million.
-   **CDT Equity** (NASDAQ:CDT) shares fell 18.63% to $4.15. The market value of their outstanding shares is at $24.0 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [COCP.US](https://longbridge.com/en/quote/COCP.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [PILL.US](https://longbridge.com/en/quote/PILL.US.md)
- [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [ETNB.CVR.US](https://longbridge.com/en/quote/ETNB.CVR.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [PFSA.US](https://longbridge.com/en/quote/PFSA.US.md)
- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)

## Related News & Research

- [BMY Stock Rises as Bristol Myers Brings Anthropic's Claude AI to 30,000 Employees](https://longbridge.com/en/news/287076466.md)
- [Bristol-Myers Squibb-Anthropic AI Deal Targets Faster Drug Discovery](https://longbridge.com/en/news/287100303.md)
- [09:24 ETTigerlily Foundation Collaborates with Bristol Myers Squibb to Advance Clinical Trial Access and Equity](https://longbridge.com/en/news/286573689.md)
- [Tempus AI, Bristol Myers Squibb Expand AI-Driven Clinical Trial Efforts](https://longbridge.com/en/news/286453944.md)
- [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md)